144 related articles for article (PubMed ID: 2077180)
1. Effects of betaxolol on cardiohemodynamics and coronary circulation in anesthetized dogs: comparison with atenolol and propranolol.
Satoh N; Suzuki J; Bessho H; Kitada Y; Narimatsu A; Tobe A
Jpn J Pharmacol; 1990 Oct; 54(2):113-9. PubMed ID: 2077180
[TBL] [Abstract][Full Text] [Related]
2. Betaxolol, a cardioselective beta-adrenoceptor antagonist, attenuates ischemic myocardial acidosis in dogs.
Abe Y; Narimatsu A; Tobe A
Jpn J Pharmacol; 1990 Jun; 53(2):185-94. PubMed ID: 2385004
[TBL] [Abstract][Full Text] [Related]
3. Effects of betaxolol, propranolol, and atenolol on isoproterenol-induced beta-adrenoceptor responses.
Riddell JG; Shanks RG
Clin Pharmacol Ther; 1985 Nov; 38(5):554-9. PubMed ID: 2865028
[TBL] [Abstract][Full Text] [Related]
4. [The effect of atenolol on contractility and hemodynamics of the infarcted heart in comparison to propranolol and practolol (author's transl)].
Stephan K; Meesmann W; Bischoff KO; Hübner H; Geigenmüller L; Diesch J
Arzneimittelforschung; 1975 Nov; 25(11):1770-6. PubMed ID: 1243085
[TBL] [Abstract][Full Text] [Related]
5. [Effect of atenolol and propranolol on systemic and regional hemodynamics].
Medvedev OS; Iuzhakov SD; Mashkovskiĭ MD; Val'dman AV; Ismailov ShI
Biull Eksp Biol Med; 1983 Jul; 96(7):59-61. PubMed ID: 6871455
[TBL] [Abstract][Full Text] [Related]
6. Effects of intracoronary propranolol on coronary blood flow and regional myocardial function in dogs.
Noguchi K; Sunagawa R; Kato T; Nagamine F; Sakanashi M
Eur J Pharmacol; 1987 Dec; 144(2):201-10. PubMed ID: 3436367
[TBL] [Abstract][Full Text] [Related]
7. Beta adrenergic blockade with propranolol and atenolol in the exercising dog: evidence for beta 2 adrenoceptors in the sinoatrial node.
Friedman DB; Musch TI; Williams RS; Ordway GA
Cardiovasc Res; 1987 Feb; 21(2):124-9. PubMed ID: 2822246
[TBL] [Abstract][Full Text] [Related]
8. Regional hemodynamic effects of betaxolol, a new selective beta 1-blocker, and atenolol in conscious spontaneously hypertensive rats.
Shoji T; Aki Y; Horiuchi K; Tamaki T; He H; Nishiyama A; Kiyomoto H; Fujisawa Y; Iwao H; Abe Y
Jpn J Pharmacol; 1992 Nov; 60(3):253-9. PubMed ID: 1491514
[TBL] [Abstract][Full Text] [Related]
9. Cocaine significantly impairs myocardial relaxation.
Henning RJ
Crit Care Med; 1993 Apr; 21(4):575-85. PubMed ID: 8472579
[TBL] [Abstract][Full Text] [Related]
10. [Atenolol, its cardioselective property for adrenergic beta-receptor blocking action and effect on the cardiac function (author's transl)].
Kanno M; Nakaya H; Hattori Y; Izumi T; Nishimura T; Sakai K; Abiko Y
Nihon Yakurigaku Zasshi; 1980 Oct; 76(7):621-32. PubMed ID: 6111522
[TBL] [Abstract][Full Text] [Related]
11. Cetamolol: cardiovascular effects of a new cardioselective beta-adrenoceptor blocker possessing partial agonistic activity and lacking membrane-stabilizing activity.
Beaulieu G; Grimes D; Muirhead C; Oshiro G
Can J Physiol Pharmacol; 1984 Jun; 62(6):610-6. PubMed ID: 6146394
[TBL] [Abstract][Full Text] [Related]
12. [Antihypertensive effect of betaxolol, a cardioselective beta-adrenoceptor antagonist, in renal hypertensive dogs].
Bessho H; Suzuki J; Kitada Y; Narimatsu A; Tobe A
Nihon Yakurigaku Zasshi; 1990 Jun; 95(6):355-60. PubMed ID: 1974239
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the cardioselectivity of five beta-adrenoceptor blocking drugs.
Pringle TH; Riddell JG; Shanks RG
J Cardiovasc Pharmacol; 1987 Aug; 10(2):228-37. PubMed ID: 2441175
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of a novel calcium entry blocking and selective beta 1-adrenoceptor blocking agent, YM-16151-4, in anesthetized and conscious dogs.
Uchida W; Shibasaki K; Asano M
J Cardiovasc Pharmacol; 1992 Jan; 19(1):60-8. PubMed ID: 1375689
[TBL] [Abstract][Full Text] [Related]
15. Adrenoceptor-blocking activity and cardiohemodynamic effects of carvedilol in animals.
Kawada T; Ishibashi T; Nakazawa M; Satoh S; Imai S
J Cardiovasc Pharmacol; 1990 Jul; 16(1):147-53. PubMed ID: 1696657
[TBL] [Abstract][Full Text] [Related]
16. Effects of the new dihydropyridine derivative 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester on the cardiohemodynamics and the energy metabolism of ischemic myocardium.
Imai H; Matsui K; Ochi S; Nakazawa M; Nakagawa Y; Imai S
Arzneimittelforschung; 1987 Dec; 37(12):1348-52. PubMed ID: 3449062
[TBL] [Abstract][Full Text] [Related]
17. [The effect of atenolol on the cardiovascular system (author's transl)].
Izumi T; Nishimura T; Sakai K; Abiko Y; Hattori Y; Nakaya H; Kanno M
Nihon Yakurigaku Zasshi; 1980 Sep; 76(6):505-13. PubMed ID: 6110622
[TBL] [Abstract][Full Text] [Related]
18. Effects of indomethacin and etodolac on coronary blood flow and other cardiovascular variables in propranolol-treated dogs.
Beaulieu G
Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):283-90. PubMed ID: 3161477
[TBL] [Abstract][Full Text] [Related]
19. Systemic and coronary hemodynamic effects of beta-adrenoceptor blocking agents in coronary artery disease.
Yabe Y; Morishita T
Jpn Heart J; 1987 Sep; 28(5):675-86. PubMed ID: 3430729
[TBL] [Abstract][Full Text] [Related]
20. Contrasting effects of betaxolol and propranolol on Ca(2+)-activated contractions in skinned fibers from canine coronary arteries and ventricular muscles.
Kitada Y
Cardiovasc Drugs Ther; 1996 Nov; 10(5):581-6. PubMed ID: 8950074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
